It is an antilipemic agent which reduces both cholesterol and triglycerides in the blood. In this domain, we are known as a reliable and trusted organization engaged in offering Fenofibrate. It is used as adjunctive therapy to diet to reduce elevated LDL-C and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia . It is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia. Fenofibrate exerts its therapeutic effects through activation of peroxisome proliferator activated receptor a (PPARa).